Rhoades K - Search Results

1

Symptomology following mRNA vaccination against SARS-CoV-2.

Ebinger JE, Lan R, Sun N, Wu M, Joung S, Botwin GJ, Botting P, Al-Amili D, Aronow H, Beekley J, Coleman B, Contreras S, Cozen W, Davis J, Debbas P, Diaz J, Driver M, Fert-Bober J, Gu Q, Heath M, Herrera E, Hoang A, Hussain SK, Huynh C, Kim L, Kittleson M, Liu Y, Lloyd J, Luong E, Malladi B, Merchant A, Merin N, Mujukian A, Nguyen N, Nguyen TT, Pozdnyakova V, Rashid M, Raedschelders K, Reckamp KL, Rhoades K, Sternbach S, Vallejo R, White S, Tompkins R, Wong M, Arditi M, Figueiredo JC, Van Eyk JE, Miles PB, Chavira C, Shane R, Sobhani K, Melmed GY, McGovern DPB, Braun JG, Cheng S, Minissian MB. Ebinger JE, et al. Among authors: rhoades k. Prev Med. 2021 Dec;153:106860. doi: 10.1016/j.ypmed.2021.106860. Epub 2021 Oct 20. Prev Med. 2021. PMID: 34687733 Free PMC article.

2

IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.

Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. Essner R, et al. Among authors: rhoades k. J Immunol. 1989 Jun 1;142(11):3857-61. J Immunol. 1989. PMID: 2785566

3

Differential effects of granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor on tumor necrosis factor and interleukin-1 production in human monocytes.

Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. Essner R, et al. Among authors: rhoades k. J Clin Lab Immunol. 1990 Aug;32(4):161-6. J Clin Lab Immunol. 1990. PMID: 1966932

4

Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line.

Economou JS, Rhoades K, Essner R, McBride WH, Gasson JC, Morton DL. Economou JS, et al. Among authors: rhoades k. J Exp Med. 1989 Jul 1;170(1):321-6. doi: 10.1084/jem.170.1.321. J Exp Med. 1989. PMID: 2746161 Free PMC article.

5

Tumour necrosis factor production by IL-2-activated macrophages in vitro and in vivo.

Economou JS, McBride WH, Essner R, Rhoades K, Golub S, Holmes EC, Morton DL. Economou JS, et al. Among authors: rhoades k. Immunology. 1989 Aug;67(4):514-9. Immunology. 1989. PMID: 2788610 Free PMC article.

6

Interleukin-4 inhibits the expression of tumour necrosis factors alpha and beta, interleukins-1 beta and -6 and interferon-gamma.

Lee JD, Rhoades K, Economou JS. Lee JD, et al. Among authors: rhoades k. Immunol Cell Biol. 1995 Feb;73(1):57-61. doi: 10.1038/icb.1995.9. Immunol Cell Biol. 1995. PMID: 7768545

7

Granulocyte-macrophage colony-stimulating factor and interleukin-4 differentially regulate the human tumor necrosis factor-alpha promoter region.

Rhoades KL, Cai S, Golub SH, Economou JS. Rhoades KL, et al. Cell Immunol. 1995 Mar;161(1):125-31. doi: 10.1006/cimm.1995.1016. Cell Immunol. 1995. PMID: 7867077

8

In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector.

Toloza EM, Hunt K, Swisher S, McBride W, Lau R, Pang S, Rhoades K, Drake T, Belldegrun A, Glaspy J, Economou JS. Toloza EM, et al. Among authors: rhoades k. Cancer Gene Ther. 1996 Jan-Feb;3(1):11-7. Cancer Gene Ther. 1996. PMID: 8785705

9

Transduction of murine and human tumors using recombinant adenovirus vectors.

Toloza EM, Hunt K, Miller AR, McBride W, Lau R, Swisher S, Rhoades K, Arthur J, Choi J, Chen L, Chang P, Chen A, Glaspy J, Economou JS. Toloza EM, et al. Among authors: rhoades k. Ann Surg Oncol. 1997 Jan;4(1):70-9. doi: 10.1007/BF02316813. Ann Surg Oncol. 1997. PMID: 8985520

10

The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines.

Rhoades KL, Golub SH, Economou JS. Rhoades KL, et al. J Biol Chem. 1992 Nov 5;267(31):22102-7. J Biol Chem. 1992. PMID: 1429562 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters